The dataset is freely available to copy, use, and redistribute for any purpose, even commercial, provided that authors are appropriately credited.
1. Z Movahedi Nia, JD Kong, Dengeu Fever in Africa (2022) http://aimmlab.org/dengue-fever-in-africa
2. Global Burden of Disease Collaborative Network. Global Burden of Disease Study 2019 (GBD 2019) Results. Seattle, United States: Institute for Health Metrics and Evaluation (IHME).
Dengue fever is a vector-borne tropical disease that is caused by the dengue virus which spreads through several species of female mosquitoes of the Aedes genus, principally aedes aegypti. Typically, symptoms which begin three to fourteen days after infection, include high fever, headache, vomiting, muscle/joint pain, and skin rash and itching. In severe cases, the disease may develop into dengue hemorrhagic fever, where bleeding, blood plasma leakage, and low levels of platelets, or into dengue shock syndrome, resulting into dangerously low blood pressure. There is an approved vaccine for dengue fever, however, since 2018, it is mainly distributed among populations with high rate of prior infection. Since the second world war, dengue fever has become a global issue, and common among more than 120 countries. About 390 million people are infected with dengue fever each African year, half a million are hospitalized, and roughly, 40000 die. Unfortunately, the number of dengue fever cases has increased over the years in some countries.
Below please find our dashboard for Dengue fever cases in Africa.
2000
Please select 8 countries at maximum.
Total Number of Cases per Year
125K
Mean Number of Cases per Year
125K
Minimum Number of Cases per Year
125K
Maximum Number of Cases per Year
125K